
Mirati Therapeutics Appoints Laurie Stelzer as Chief Financial Officer
SAN DIEGO, May 16, 2022 /PRNewswire/ — Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today announced the appointment of Laurie Stelzer as the Company’s Chief Financial Officer (CFO) effective May 16, 2022. […]